Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 5/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.33 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11903070 | 0.92 | NOS1 (0.35) | NOS1ACLYTAS1R3TAS1R1TAS1R2 | |
| SCHEMBL11903434 | 0.87 | TAS1R3 (0.34) | ACLYTAS1R3TAS1R1TAS1R2MEP1B | |
| SCHEMBL11918004 | 0.83 | NOS1 (0.34) | NOS1KIF11 | |
| SCHEMBL1653944 | 0.81 | ACLY (0.35) | ACLYTAS1R3TAS1R1TAS1R2MEP1B | |
| SCHEMBL11903420 | 0.80 | ALDH1A1 (0.37) | ACLYTAS1R3TAS1R1TAS1R2MEP1B | |
| SCHEMBL11902935 | 0.76 | TAS1R3 (0.35) | TAS1R3TAS1R1TAS1R2MEP1BSUCNR1 | |
| SCHEMBL117789 | 0.76 | TAS1R3 (0.40) | ACLYTAS1R3TAS1R1TAS1R2MEP1B | |
| SCHEMBL1115268 | 0.74 | TAS1R3 (0.39) | ACLYTAS1R3TAS1R1TAS1R2MEP1B | |
| SCHEMBL1654712 | 0.74 | MEP1B (0.38) | ACLYTAS1R3TAS1R1TAS1R2MEP1B | |
| SCHEMBL716664 | 0.74 | TAS1R3 (0.38) | ACLYTAS1R3TAS1R1TAS1R2MEP1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | DDT, HAO2, HAAO | NOS1 780/4885ACLY 537/4885TAS1R3 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.